Form 483

Rentschler Biopharma SE Form 483, 2016-12-06

FDA issued a Form 483 to Rentschler Biopharma SE on 2016-12-06 with 1 public-safe observation.

483· Form 483 issuedHuman Drugs1 observation

Rentschler Biopharma SE · Laupheim, Germany · Issued December 6, 2016

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

6 Dec 2016
21 CFR 211.63

Equipment Design, Size and Location

Cited by Truong X Nguyen, Djamila Harouaka

Inspected site

RBRentschler Biopharma SELaupheim, Germany

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.63Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere